Skip to main content

Table 2 Association of total cholesterol with all-cause, cardiovascular, and non-cardiovascular mortality

From: Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study

Total

 

All-cause mortality

Cardiovascular mortality

Non-cardiovascular mortality

cholesterol (mmol/l)

No. of subjects

No. of deaths

Mortality rate (per 1000 person-years)

Hazard ratio (95% CI)a

No. of deaths

Mortality rate (per 1000 person-years)

Hazard ratio (95% CI)b

No. of deaths

Mortality rate (per 1000 person-years)

Hazard ratio (95% CI)b

Total sample

  < 5.18

687

325

71.8

1.00 (Ref.)

205

45.3

1.00 (Ref.)

120

26.5

1.00 (Ref.)

 5.18–6.21

1207

394

43.2

0.71 (0.61–0.83)

236

25.9

0.82 (0.66–1.02)

158

17.3

0.85 (0.66–1.09)

  ≥ 6.22

1196

340

35.6

0.68 (0.57–0.80)

221

23.2

0.98 (0.77–1.23)

119

12.5

0.67 (0.51–0.88)

P for trend

   

<0.001a

  

0.882b

  

0.004b

No use of cholesterol-lowering medications

  < 5.18

495

259

84.7

1.00 (Ref.)

162

53.0

1.00 (Ref.)

97

31.7

1.00 (Ref.)

 5.18–6.21

1066

358

44.7

0.70 (0.59–0.82)

213

26.6

0.79 (0.63–1.00)

145

18.1

0.88 (0.67–1.16)

  ≥ 6.22

1140

324

35.5

0.65 (0.54–0.77)

209

22.9

0.91 (0.72–1.17)

115

12.6

0.69 (0.51–0.92)

P for trend

   

<0.001a

  

0.573b

  

0.009b

Use of cholesterol-lowering medications

  < 5.18

189

64

44.0

1.00 (Ref.)

42

28.9

1.00 (Ref.)

22

15.1

1.00 (Ref.)

 5.18–6.21

138

33

29.6

0.76 (0.49–1.19)

22

19.7

0.84 (0.47–1.50)

11

9.9

0.75 (0.35–1.61)

  ≥ 6.22

54

14

33.2

1.03 (0.56–1.90)

11

26.0

1.47 (0.77–2.81)

3

7.1

0.52 (0.14–1.98)

P for trend

   

0.961a

  

0.561b

  

0.244b

  1. aHazard ratios (95% confidence intervals, CIs) were derived from Cox regression models that were controlled for age, sex, education, current smoking, heavy alcohol drinking, physical inactivity, obesity, hypertension, diabetes, APOE ε4 allele, cognitive impairment, mobility limitation, and if applicable, for use of cholesterol-lowering drugs
  2. bHazard ratios (95% CIs) were derived from the competing risks model that was controlled for all variables mentioned in the above footnote